Nektar Therapeutics
Polymer-des-ethyl sunitinib conjugates
Last updated:
Abstract:
The invention relates to (among other things) polymer-des-ethyl sunitinib conjugates and related compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits advantages over des-ethyl sunitinib in unconjugated form.
Status:
Grant
Type:
Utility
Filling date:
9 Jan 2019
Issue date:
9 Aug 2022